Defense Health Agency Transition and Policy Updates

Description

On October 1, 2018, the Defense Health Agency (DHA) launched a phased approach to assume responsibility for the administration and management of health care at all military medical treatment facilities (MTFs). This transition, mandated by the 2017 National Defense Authorization Act, is intended to create an integrated, efficient and effective system of readiness and health that better supports the joint forces, although each service will remain responsible for operational mission support and readiness. A top leader at the Defense Health Agency (DHA) provides an update on the DHA transition, including policy updates, and a vision of the future of federal pharmacy within this new structure. 

Pharmacist Learning Objectives

At the completion of this activity, participants will be able to:

  1. Provide an overview of the Defense Health Agency (DHA) transition and how it supports the joint forces.
  2. Describe policy updates and how they impact mission support and readiness.
  3. Discuss the future of federal pharmacy within the new structure.



 

 

 

     

Technician Learning Objectives

At the completion of this activity, participants will be able to:

  1. Provide an overview of the Defense Health Agency (DHA) transition and how it supports the joint forces.
  2. Describe policy updates and how they impact mission support and readiness.
  3. Discuss the future of federal pharmacy within the new structure.

 

     

 
 
 
Speakers:
Ronald
Ronald Place, MD
.
Defense Health Agency
 
Learning Level: Level 1
Track: Readiness, General Session, Pharmacy Business Operations, Management, and Professional Leadership
Session Time Slot(s): 
Date: 
Monday, October 28
Time: 
8:30 AM - 9:15 AM
Room: 
Hilton Anatole Dallas - Chantilly Ballroom
ACPE Pharmacist: 0202-0000-19-176-L04-P
CEUs Pharmacist: .075
ACPE Pharmacy Technician: 0202-0000-19-176-L04-T
CEUs Pharmacy Technician: .075
Activity Type:
Knowledge-based